What can we do for you?
No. 2 on the A-List 2024
Ropes & Gray has been ranked No. 2 on The American Lawyer’s A-List—our eighth consecutive top-three ranking on the prestigious list.
The American Lawyer’s 2024 Pharma and Health Care Corporate Practice of the Year
Ropes & Gray’s life sciences and healthcare teams delivered exceptional results for clients, steering transformative deals and facilitating over 110 complex licensing and collaboration transactions with an aggregate value of $55 billion.
Latest Insights
Alert
Dealmaker's Digest: A Top 10 Bulletin - February 2025
In Dealmaker’s Digest, read the top 10 latest developments in global transactions. We offer insights into M&A activity across industries and borders.
Alert
Special Situations Credit: 2024 Year In Review and 2025 Outlook
As expected, we experienced continued strong deal flow for special situations credit transactions in 2024, with both macroeconomic and industry-specific factors broadly impacting markets.
Alert
Enforcement under the Trump Administration: Reports of the FCPA’s Death are Exaggerated
On February 10, 2025, President Trump issued an executive order (the “EO”) directing the U.S. Department of Justice (“DOJ”) to pause new Foreign Corrupt Practices Act (“FCPA”) investigations and enforcement actions for 180 days while the DOJ reviews existing guidelines and policies governing FCPA, a federal law that prohibits bribery of foreign public officials.

United in the Fight Against Cancer
Through our work with clients, public service and support of our own community, Ropes & Gray is committed to the battle against cancer.
Ropes & Gray
By the numbers
0+
Attorneys worldwide
0
Offices
0+
2024 pro bono hours
0
Consecutive years on A-List of elite firms
